The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prospective phase I study of nab-paclitaxel plus gemcitabine with concurrent MR-guided IMRT in patients with locally advanced or borderline resectable pancreatic cancer.
 
Jeffrey R. Olsen
Honoraria - ViewRay
Research Funding - ViewRay
Patents, Royalties, Other Intellectual Property - Varian Medical Systems (I)
 
Parag J. Parikh
No Relationships to Disclose
 
Todd A. DeWees
Consulting or Advisory Role - Traxxsson
 
Lindsey Olsen
Honoraria - ViewRay (I)
Research Funding - ViewRay (I)
Patents, Royalties, Other Intellectual Property - Varian Medical Systems
 
William G. Hawkins
No Relationships to Disclose
 
Steven M. Strasberg
No Relationships to Disclose
 
Kian-Huat Lim
Stock and Other Ownership Interests - Merck
Consulting or Advisory Role - Idera
 
Preet Paul Singh
No Relationships to Disclose
 
Rama Suresh
No Relationships to Disclose
 
Benjamin R. Tan
Consulting or Advisory Role - Roche/Genentech
Research Funding - Bayer; Eisai; Exelixis; Lilly; Merck Serono; Pfizer; Roche/Genentech; Xcovery
 
Lee Ratner
No Relationships to Disclose
 
Ryan C. Fields
No Relationships to Disclose
 
Manik A. Amin
Research Funding - Spectrum Pharmaceuticals
 
Andrea Wang-Gillam
Honoraria - Merrimack; Pfizer
Consulting or Advisory Role - Merrimack; Pfizer
Research Funding - Aduro Biotech; CTI; EMD Serono; Halozyme; Merrimack; Millennium; Newlink Genetics; OncoMed; Pfizer; Precision Therapeutics
Travel, Accommodations, Expenses - Axis Pharma